API Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (Websockets) API Financial News API Delisted Data API
Solutions
New & Popular APIs
Show all APIs Fundamental Data APIs Historical End-of-Day API Financial Events & News API Indices Historical Constituents API 40 000 Stock Market Logos API Forex Data APIs
Other products
Google Sheets Add-on Excel Add-on Coding Libraries (Python, R, etc) Wordpress Add-on
API Marketplace
Community
Academy 152 articles Forum Github 14 repos
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. V /
  3. ARCH.V

Arch Biopartners Inc (ARCH V) stock market data APIs

C$2.54 0.5(24.5%) as of October 21, 2024
Price chart is built with Anychart

Arch Biopartners Inc., together with its subsidiaries, engages in the development of therapeutic drugs for inflammation and acute organ injuries in Canada. It focuses on developing its lead drug candidate LSALT Peptide, a product in Phase 2 clinical trials to treat dipeptidase-1 mediated organ inflammation in the lungs, liver, and kidneys. The company also develops AB569 for treating antibiotic-resistant bacterial infections, and for the treatment of wounds; and Borg, a peptide-solid surface interface to reduce corrosion of metals. Arch Biopartners Inc. is based in Toronto, Canada.

Arch Biopartners Inc Financial Data Overview

2.06
2.54
-
2.52
2.26
0.97-2.56
132 M
64 651 K
1 384 K
-0.01
1.394
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ARCH',
Type: 'Common Stock',
Name: 'Arch Biopartners Inc',
Exchange: 'V',
CurrencyCode: 'CAD',
CurrencyName: 'Canadian Dollar',
CurrencySymbol: 'C$',
CountryName: 'Canada',
CountryISO: 'CA',
OpenFigi: NULL,
ISIN: 'CA03938C1041',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'September',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Arch Biopartners Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 384 K
  • EBITDA 0
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Arch Biopartners Inc Earnings via APIs

  • Latest Release 2024-08-28
  • EPS/Forecast -0.02

Get Arch Biopartners Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Arch Biopartners Inc latest news via APIs

Shares for Interest Debt Settlement

TORONTO, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Company has arranged a shares for de...
  • ARCH BIOPARTNERS
  • MAJOR SHAREHOLDER ANNOUNCEMENTS
  • TSX VENTURE EXCHANGE:ARCH

Arch Biopartners Submits Application to the Turkish Ministry of Health to Conduct a Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide

TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that it has submitted applications to the Ministr...
  • ACUTE KIDNEY INJURY TREATMENT
  • ARCH BIOPARTNERS
  • CHRONIC KIDNEY DISEASE
  • CLINICAL STUDY
  • DOD
  • HEALTH
  • KIDNEY FOUNDATION
  • NORDISK
  • NOVARTIS
  • SAVE KIDNEYS
  • TREAT INFLAMMATION
  • TSX VENTURE EXCHANGE:ARCH
News API is available at any package from $19.99 See full price
Get sample of News API
Do you have any questions?
support@eodhistoricaldata.com